Open Orphan PLC
LSE:ORPH
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
UK |
O
|
Open Orphan PLC
LSE:ORPH
|
67.1m GBP | 0 | |
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
224.6B USD | 14.5 | ||
US |
Danaher Corp
NYSE:DHR
|
196.7B USD | 8.1 | ||
US |
Agilent Technologies Inc
NYSE:A
|
44.5B USD | 13.4 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.3B USD | 10.1 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
54.8T KRW | 28.5 | ||
CH |
Lonza Group AG
SIX:LONN
|
36.8B CHF | 15.7 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
31.9B USD | 15 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.2B USD | 12 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
24.2B USD | 21.8 | ||
US |
Waters Corp
NYSE:WAT
|
20.4B USD | 12.7 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.